Pharma Journalist -

Roche has announced positive results from the Phase III evERA study evaluating giredestrant combined with everolimus in patients with estrogen receptor (ER)-positive, HER2-negative,…
Read More...

Moderna, Inc. has announced promising preliminary immunogenicity results for the 2025-2026 formula of its COVID-19 vaccine, mNEXSPIKE, which targets the SARS-CoV-2 LP.8.1 variant. Data…
Read More...

Eli Lilly and Company announced plans to construct a $6.5 billion state-of-the-art manufacturing facility at Generation Park in Houston, Texas. This new site will focus on producing…
Read More...

Servier, the independent international pharmaceutical group, announced that the European Commission (EC) has approved VORANIGO (vorasidenib) for treating predominantly non-enhancing…
Read More...

The U.S. Food and Drug Administration (FDA) has extended the target action date for its review of Sanofi’s new drug application (NDA) for tolebrutinib by three months, now set for…
Read More...

Minovia Therapeutics Ltd., a clinical-stage biotech focused on mitochondrial diseases and age-related conditions, has announced that the U.S. Food and Drug Administration (FDA) has…
Read More...

Novo Nordisk announced new findings from the REACH real-world study demonstrating that Ozempic (once-weekly injectable semaglutide) reduced the risk of major adverse cardiovascular…
Read More...

FUJIFILM Biotechnologies, a leading contract development and manufacturing organization (CDMO), announced a major expansion of its global partnership with immunology company argenx SE.…
Read More...

Roche announced that it has entered into a definitive agreement to acquire 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company developing innovative therapies for…
Read More...

Biogen Inc. announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE (zuranolone) as a treatment for postpartum depression (PPD) in adults following…
Read More...